CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
The BALXPAND project focuses on developing a bioartificial liver, the HepaRG-AMC-BAL, which aims to support patients with end-stage liver disease. This innovative system connects to a patient's circulation to stabilize liver function while addressing the shortage of donor organs.
End-stage liver disease patients suffer from a dramatic loss of functional liver tissue, which leads to 50-80% mortality.
Liver transplantation is the only effective therapy.
However, this life supporting therapy is limited by the shortage of donor livers.
As a consequence many patients die while on the transplantation waiting list.
The SME Hep-Art has developed a bioartificial liver, the HepaRG-AMC-BAL, that has already shown to increase the survival time in animals with severe liver failure. T…
HEP-ART MEDICAL DEVICES BV
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
